You just read:

MedyMatch Receives Expedited Access Pathway / Breakthrough Device Designation from the FDA to Accelerate Market Access for Intracranial Hemorrhage Software

News provided by

MedyMatch Technology

Jan 29, 2018, 07:00 ET